Scientists discover mechanism that controls spread of pancreatic cancer

The findings could ultimately pave the way for new treatments of the disease, the researchers suggest.

Scientists discover mechanism that controls spread of pancreatic cancer (Luciana Guerra/PA)
Scientists discover mechanism that controls spread of pancreatic cancer (Luciana Guerra/PA)

It is possible to reverse a key process that allows pancreatic cancer cells to grow and spread around the body, scientists have found.

Researchers suggest the findings could ultimately pave the way for new treatments of the disease.

The study shows that a protein called GREM1 is key to controlling the type of cells found in pancreatic cancer.

According to the researchers, manipulating the levels of this protein can both fuel and reverse the ability of these cells to become more aggressive.

This is an important and fundamental discovery that opens up a new avenue for uncovering treatments for pancreatic cancer

Professor Axel Behrens, ICR

Professor Axel Behrens, leader of the Cancer Stem Cell Team at The Institute of Cancer Research, London (ICR) was senior author of the study.

He said: “This is an important and fundamental discovery that opens up a new avenue for uncovering treatments for pancreatic cancer.

“We have shown that it is possible to reverse cell fate in pancreatic cancer in the lab – turning back the clock on aggressive tumours and switching them to a state that makes them easier to treat.

“By better understanding what drives the aggressive spread of pancreatic cancer, we hope to now exploit this knowledge and identify ways to make pancreatic cancer less aggressive, and more treatable.”

Pancreatic cancer has the lowest survival rates of common cancers.

Less than 7% of people will survive for five years or more.

In the UK, more than 10,000 people are diagnosed with pancreatic cancer each year, and more than 9,000 will die from it.

The ICR researchers studied pancreatic cancer with the gene that makes the GREM1 protein switched off in mice, and in pancreatic ‘mini-tumours’, which are also known as organoids.

They found that switching off the GREM1 caused the tumour cells to rapidly change shape and develop new properties that help them invade new tissues and migrate around the body.

Within 10 days, all the tumour cells changed their identity into a dangerous, invasive cell type, researchers found.

But crucially, the scientists discovered that boosting GREM1 levels could reverse this process and cause invasive cell types to revert into a less dangerous form.

Researchers hope to use this knowledge to find ways to reverse more advanced pancreatic cancer into a less aggressive form, which is easier to treat.

However, the science is at an early stage, and significant further research is needed.

The findings are published in Nature.

Professor Kristian Helin, chief executive of the ICR, said: “Pancreatic cancer is one of the most devastating of all cancers – the most common form of the disease spreads aggressively, making it hard to treat and a terrifying diagnosis for patients and their loved ones.

“This new finding has broadened our understanding of the molecular basis of how pancreatic cancer gains the ability to grow and spread around the body.

“Although more work is required, this type of fundamental research is essential for developing concepts for new and more effective treatments for cancer.”

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in